Literature DB >> 17318311

[Conductive bone substitute material with variable antibiotic delivery].

C Englert1, P Angele, J Fierlbeck, S Dendorfer, T Schubert, R Müller, S Lienhard, J Zellner, M Nerlich, C Neumann.   

Abstract

BACKGROUND: A new bone substitute, consisting of hydroxylapatite and calcium sulphate, was prepared in two formulations and analysed for its mechanical strength and antibiotic elution.
MATERIAL AND METHODS: The bone substitute PerOssal has osteoconductive and degradable properties. The material has a built-in capillary structure, which results in an immediate fluid uptake. Antibiotics absorbed to the bone substitute resulted in a prolonged release rate. Mechanical strength was investigated by an unconfined compression test up to failure under both wet and dry conditions for both formulations of the bone substitute. Antibiotic release was analysed microbiologically for two antibiotics, vancomycin and gentamicin, over an elution period of 10 days using the agar diffusion method.
RESULTS: The drug release analysis resulted in a prolonged release rate of both antibiotics over 10 days. In vitro the amount of gentamicin and vancomycin eluted at day 10. From one pellet still exceeded the minimal inhibitory concentration of most aetiologically important pathogens. Formulation two of the present bone substitute is significantly harder in both wet and dry conditions when compared to formulation one. Both formulations lose strength in the wet condition relative to their performance in the dry condition. However, formulation two is as hard under wet conditions as formulation one is when dry.
CONCLUSION: PerOssal is a suitable new degradable osteoconductive bone substitute that can be loaded with antibiotic solutions, which are released in effective doses over 10 days. The mechanical strength of PerOssal is sufficient to support cancellous bone defects in non-weight-bearing areas or in combination with osteosynthesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318311     DOI: 10.1007/s00113-007-1229-3

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  30 in total

1.  [Tibial plateau fracture--biodegradable bonecement-augmentation].

Authors:  T Engel; H Lill; J Korner; P Verheyden; C Josten
Journal:  Unfallchirurg       Date:  2003-02       Impact factor: 1.000

2.  Biomechanical considerations of animal models used in tissue engineering of bone.

Authors:  Michael A K Liebschner
Journal:  Biomaterials       Date:  2004-04       Impact factor: 12.479

3.  [Treatment of chronic osteitis of the femur].

Authors:  H G Schmidt; F Wittek; M Faschingbauer; B Fink
Journal:  Unfallchirurg       Date:  1992-11       Impact factor: 1.000

4.  Complications associated with bone cementing for the treatment of giant cell tumors of bone.

Authors:  Takuro Wada; Mitsunori Kaya; Satoshi Nagoya; Satoshi Kawaguchi; Kazuo Isu; Toshihiko Yamashita; Shinya Yamawaki; Seiichi Ishii
Journal:  J Orthop Sci       Date:  2002       Impact factor: 1.601

5.  Adult posttraumatic osteomyelitis of the tibial diaphysis of the tibial shaft.

Authors:  D Seligson; K Klemm
Journal:  Clin Orthop Relat Res       Date:  1999-03       Impact factor: 4.176

6.  Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections.

Authors:  Michael A Rauschmann; Thomas A Wichelhaus; Volker Stirnal; Elvira Dingeldein; Ludwig Zichner; Reinhard Schnettler; Volker Alt
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

7.  [Antibiotic-containing collagen sponge in therapy of osteitis].

Authors:  E Wernet; A Ekkernkamp; H Jellestad; G Muhr
Journal:  Unfallchirurg       Date:  1992-05       Impact factor: 1.000

8.  Comparison of the clinical efficacy and tolerance of gentamicin PMMA beads on surgical wire versus combined and systemic therapy for osteomyelitis.

Authors:  J D Blaha; J H Calhoun; C L Nelson; S L Henry; D Seligson; J L Esterhai; R B Heppenstall; J Mader; R P Evans; J Wilkins
Journal:  Clin Orthop Relat Res       Date:  1993-10       Impact factor: 4.176

9.  Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo.

Authors:  U Joosten; A Joist; T Frebel; B Brandt; S Diederichs; C von Eiff
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

Review 10.  Tibial plateau fractures. Management and expected results.

Authors:  H Tscherne; P Lobenhoffer
Journal:  Clin Orthop Relat Res       Date:  1993-07       Impact factor: 4.176

View more
  3 in total

1.  [Collagen hydroxyapatite (Healos) saturated with gentamicin or levofloxacin. In vitro antimicrobial effectiveness - a pilot study].

Authors:  C H Fürstenberg; B Wiedenhöfer; C Putz; I Burckhardt; S Gantz; K Kleinschmidt; K Schröder
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

2.  Biomaterials for craniofacial reconstruction.

Authors:  Andreas Neumann; Kevin Kevenhoerster
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-03-10

3.  A novel injectable borate bioactive glass cement as an antibiotic delivery vehicle for treating osteomyelitis.

Authors:  Hao Ding; Cun-Ju Zhao; Xu Cui; Yi-Fei Gu; Wei-Tao Jia; Mohamed N Rahaman; Yang Wang; Wen-Hai Huang; Chang-Qing Zhang
Journal:  PLoS One       Date:  2014-01-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.